ArticlePaediatric drugs2017

Palivizumab Exposure and the Risk of Atopic Dermatitis, Asthma and Allergic Rhinoconjunctivitis: A Cross-National, Population-Based Cohort Study.

Ann Haerskjold et al.PubMed ↗Publisher ↗

No numbers read from the abstract.